Martin Hamblin GfK Acquires Additional Healthcare Services

At the end of last year, Martin Hamblin GfK acquired several PMSI services based at High Wycombe in the UK from IMS HEALTH.

The services are Generator, the face-to-face monthly GP and specialist omnibus, MARS, the advertising assessment tool and Detail Follow Ups. These services and the research staff who manage them will now be merging with Martin Hamblin GfK's Healthcare Division, operating in the UK and globally. PMSI and its Scriptrac and Prospector services remain with IMS HEALTH.

The acquisition gives Martin Hamblin GfK one of the key omnibus services in UK healthcare. The established services of MARS and Detail Follow-up test (DFU) include databases with years of normative data.

Allan Bowditch, Global CEO for Martin Hamblin GfK's Healthcare Division and based in the US, commented 'The acquisition expands the Martin Hamblin GfK offering in the UK and allows us to explore possible rollout into other countries of these UK services.'

Stephen Grundy and Angela Duffy are Joint Managing Directors for the Healthcare Division based in the UK and are looking forward to integrating these services and the people who manage them into the business over the next few months. Angela commented 'The acquisition of these services is excellent news for Martin Hamblin GfK. As Healthcare is a core part of our business, this purchase fits in perfectly with our strategy of developing Healthcare Research and expanding our offering to existing clients.'

This acquisition follows Martin Hamblin GfK's recent purchase from IMS HEALTH of its Veterinary research business including the British Veterinary Index and the Veterinary Sales Territory Services a few months ago.

All articles 2006-22 written and edited by Mel Crowther and/or Nick Thomas unless otherwise stated.

• IMS Health Inc
• All news